Xiaoke Di

4PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 04, 2026
RILPL2 suppresses metabolic reprogramming and progression of cervical cancer by attenuating LDHA protein stability and inhibiting H3K18 lactylation.

|Jun 27, 2025
Correction: Hypoxia inhibits ferritinophagy-mediated ferroptosis in esophageal squamous cell carcinoma via the USP2-NCOA4 axis.

Jiahang Song, Junfeng Zhang, Yujing Shi

|May 14, 2024
Hypoxia inhibits ferritinophagy-mediated ferroptosis in esophageal squamous cell carcinoma via the USP2-NCOA4 axis.

Jiahang Song, Junfeng Zhang, Yujing Shi

|Oct 28, 2022
Identification of Immune and Hypoxia Risk Classifier to Estimate Immune Microenvironment and Prognosis in Cervical Cancer.

Yujing Shi, Qing Gao, Zeyuan Liu

Pageof 1

Frequent Collaborators

1 joint publications

Yujing Shi

1 joint publications

Qing Gao

1 joint publications

Zeyuan Liu

1 joint publications

Gefenqiang Shen